Biorealites, S.A.S.
Records under this name other than patents Biorealites, S.A.S. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Biorealites, S.A.S.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,611,320 | Monoclonal Antibodies to Progastrin and Their Uses Formerly held In force · High confidence | In force | High confidence | |
| US 9,487,582 | Methods for Treating Pancreatic Cancer Formerly held Lapsed on the fee record Ended Nov 8, 2024 · High confidence | Lapsed on the fee record | Ended Nov 8, 2024 | High confidence |
| US 10,533,050 | Methods and Compositions for Liver Cancer Therapy Formerly held Lapsed on the fee record Ended Jan 14, 2024 · High confidence | Lapsed on the fee record | Ended Jan 14, 2024 | High confidence |
| US 9,217,032 | Methods for Treating Colorectal Cancer Formerly held Lapsed on the fee record Ended Dec 22, 2023 · High confidence | Lapsed on the fee record | Ended Dec 22, 2023 | High confidence |
| US 8,900,588 | Methods for Treating Breast Cancer Formerly held Lapsed on the fee record Ended Dec 2, 2022 · High confidence | Lapsed on the fee record | Ended Dec 2, 2022 | High confidence |
| US 8,900,817 | Progastrin and Liver Pathologies Formerly held Lapsed on the fee record Ended Dec 2, 2022 · High confidence | Lapsed on the fee record | Ended Dec 2, 2022 | High confidence |